These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2946155)

  • 1. Molecular characteristics of extracellular matrix-associated glycosaminoglycans in the endothelium.
    Wang ZW; Irimura T; Nakajima M; Belloni PN; Nicolson GL
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):152-6. PubMed ID: 2946155
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
    Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
    J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycan production in cultures of early and late passage human endothelial cells: the influence of an anionic endothelial cell growth factor and the extracellular matrix.
    Gordon PB; Conn G; Hatcher VB
    J Cell Physiol; 1985 Dec; 125(3):596-607. PubMed ID: 3905832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycans synthesized by cultured bovine corneal endothelial cells.
    Robinson J; Gospodarowicz D
    J Cell Physiol; 1983 Dec; 117(3):368-76. PubMed ID: 6418749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
    Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basement membrane degradative enzymes as possible markers of tumor metastasis.
    Nakajima M; Welch DR; Irimura T; Nicolson GL
    Prog Clin Biol Res; 1986; 212():113-22. PubMed ID: 2940601
    [No Abstract]   [Full Text] [Related]  

  • 10. Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells.
    Hennes R; Frantzen F; Keller R; Schirrmacher V; Schwartz-Albiez R
    Br J Cancer; 1988 Aug; 58(2):186-8. PubMed ID: 2971387
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequestration and release of basic fibroblast growth factor.
    Vlodavsky I; Bashkin P; Ishai-Michaeli R; Chajek-Shaul T; Bar-Shavit R; Haimovitz-Friedman A; Klagsbrun M; Fuks Z
    Ann N Y Acad Sci; 1991; 638():207-20. PubMed ID: 1664685
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase, a potential regulator of cell-matrix interactions.
    Dempsey LA; Brunn GJ; Platt JL
    Trends Biochem Sci; 2000 Aug; 25(8):349-51. PubMed ID: 10916150
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparan sulfate degradation in tumor cell invasion and angiogenesis.
    Vlodavsky I; Eldor A; Bar-Ner M; Fridman R; Cohen IR; Klagsbrun M
    Adv Exp Med Biol; 1988; 233():201-10. PubMed ID: 2464906
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase.
    Naparstek Y; Cohen IR; Fuks Z; Vlodavsky I
    Nature; 1984 Jul 19-25; 310(5974):241-4. PubMed ID: 6205275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate.
    Sewell RF; Brenchley PE; Mallick NP
    Biochem J; 1989 Dec; 264(3):777-83. PubMed ID: 2533499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of heparan sulfate moieties in cultured endothelial cells exposed to endotoxin.
    Colburn P; Dietrich CP; Buonassisi V
    Arch Biochem Biophys; 1996 Jan; 325(1):129-38. PubMed ID: 8554337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cellulose-binding domain-fused recombinant human T cell connective tissue-activating peptide-III manifests heparanase activity.
    Rechter M; Lider O; Cahalon L; Baharav E; Dekel M; Seigel D; Vlodavsky I; Aingorn H; Cohen IR; Shoseyov O
    Biochem Biophys Res Commun; 1999 Feb; 255(3):657-62. PubMed ID: 10049766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of platelet heparanase during inflammation: role of pH and proteinases.
    Ihrcke NS; Parker W; Reissner KJ; Platt JL
    J Cell Physiol; 1998 Jun; 175(3):255-67. PubMed ID: 9572470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G; Bjornsson TD; Vlodavsky I
    J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.